Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-1076-2018

Drug recall · August 22, 2018

Acne Treatment Pads recall

Why: Subpotent drug: The product active ingredient level not matching the exact levels indicated on the packaging label.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Acne Treatment Pads (2% salicylic acid), packaged in a 50-count jar, OTC, Distributed by: Greenbrier International, Inc. 500 Volvo Parkway, Chesapeake, VA 23320, NDC 71537-001-02

Lots / codes

Lot # 2458067, Exp 11/2019

Quantity
75,000 pads
Company
Huijing (Shanghai) Bio-tech Co., Ltd., Shanghai
Distribution
Product was distributed to one distributor in VA
Initiated
August 3, 2018 · Voluntary: Firm initiated
Classified
August 10, 2018
Reported
August 22, 2018
Ended
December 19, 2018
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Salicylic acid

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.